Yonsei Med J.  2017 Nov;58(6):1249-1251. 10.3349/ymj.2017.58.6.1249.

Percutaneous Drainage and Povidone-Iodine Sclerotherapy of Cervical Lymphatic Malformation

• Kim SH
• Lee MS
• Lim GC
• Song CI

• KMID: 2418911
• DOI: http://doi.org/10.3349/ymj.2017.58.6.1249

Abstract

Lymphatic malformations in cases with macrocystic lesions can be treated with surgical excision or sclerotherapy using alcohol, bleomycin, doxycycline, or OK-432. We report a case of a 24-year-old woman who underwent percutaneous drainage and povidone-iodine sclerotherapy as primary treatment for cervical lymphatic malformation. The patient underwent povidone-iodine sclerotherapy for 3 consecutive days. After 8 months, ultrasonography of the lesion in the neck revealed complete resolution of the cervical lymphatic malformation without any complication. Povidone-iodine sclerotherapy can be a safe and cost-effective treatment option for cervical lymphatic malformation.

Keyword

Lymphatic malformation; povidone-iodine; sclerotherapy

MeSH Terms

Anti-Infective Agents, Local/administration & dosage/*therapeutic use
Drainage/*methods
Female
Humans
Lymphatic Abnormalities/diagnostic imaging/*therapy
Neck/*diagnostic imaging
Povidone-Iodine/administration & dosage/*therapeutic use
Sclerotherapy/*methods
Tomography, X-Ray Computed
Treatment Outcome
Ultrasonography
Young Adult
Anti-Infective Agents, Local
Povidone-Iodine

Figure

• 

  Fig. 1 Computed tomographic images of 24-year-old woman showed a 5.5 cm-sized unilocular thin-walled cystic lymphatic malformation (asterisk) in the posterior triangle of the right neck. The cyst is located between the Inferior belly of omohyoid muscle (arrow) and scalene muscles (arrowheads). (A) Axial view. (B) Coronal view.

• 

  Fig. 2 A catheter (arrow) was inserted in the cystic lymphatic malformation (asterisk), through which a mixture of contrast medium and lidocaine was injected in order to induce intracystic anesthesia and ensure no fluid leak from the cyst.

• 

  Fig. 3 One month and 8 month follow-up ultrasonographic images of the right supraclavicular fossa revealed complete shrinkage and non-visualization of the cervical lymphatic malformation which was located adjacent to the scalene muscles (arrowheads) and the right subclavian vein (arrows). (A) One month follow-up. (B) Eight month follow-up.

Reference

1. Kumar V, Abbans AK, Fausto N. Robbins and Cotran pathologic basis of disease. 7th ed. Philadelphia (PA): Elsevier Saunders;2005.

2. Olímpio Hde O, Bustorff-Silva J, Oliveira Filho AG, Araujo KC. Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children. Clinics (Sao Paulo). 2014; 69:505–508.

3. Lee BB, Kim YW, Seo JM, Hwang JH, Do YS, Kim DI, et al. Current concepts in lymphatic malformation. Vasc Endovascular Surg. 2005; 39:67–81.

4. Acevedo JL, Shah RK, Brietzke SE. Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg. 2008; 138:418–424.

5. Kim KH, Sung MW, Roh JL, Han MH. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg. 2004; 131:307–316.

6. Mathur NN, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhinolaryngol. 2005; 69:75–80.

7. Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg. 1995; 30:1282–1287.

8. Bloom DC, Perkins JA, Manning SC. Management of lymphatic malformations. Curr Opin Otolaryngol Head Neck Surg. 2004; 12:500–504.

9. Wiegand S, Eivazi B, Zimmermann AP, Sesterhenn AM, Werner JA. Sclerotherapy of lymphangiomas of the head and neck. Head Neck. 2011; 33:1649–1655.

10. Cheng J. Doxycycline sclerotherapy in children with head and neck lymphatic malformations. J Pediatr Surg. 2015; 50:2143–2146.

11. Shrestha A, Shrestha PM, Verma R. Is single dose povidone iodine sclerotherapy effective in chyluria? Int Urol Nephrol. 2014; 46:1059–1062.

12. Lachapelle JM. A comparison of the irritant and allergenic properties of antiseptics. Eur J Dermatol. 2014; 24:3–9.

13. Lachapelle JM. Allergic contact dermatitis from povidone-iodine: a re-evaluation study. Contact Dermatitis. 2005; 52:9–10.

14. Vermeulen H, Westerbos SJ, Ubbink DT. Benefit and harm of iodine in wound care: a systematic review. J Hosp Infect. 2010; 76:191–199.

15. Gilliland JD, Spies JB, Brown SB, Yrizarry JM, Greenwood LH. Lymphoceles: percutaneous treatment with povidone-iodine sclerosis. Radiology. 1989; 171:227–229.

16. Seelig MH, Klingler PJ, Oldenburg WA. Treatment of a postoperative cervical chylous lymphocele by percutaneous sclerosing with povidone-iodine. J Vasc Surg. 1998; 27:1148–1151.